UACA antibody
Quick Overview for UACA antibody (ABIN7865752)
Target
See all UACA AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- anti-UACA mouse monoclonal, AE-5, purified
-
Purification
- affinity chromatography
-
Immunogen
- nuclei of myeloid leukemia biopsy cells
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 1-2 μg/million cells in 0,1 ml, fix cells in 4 % PFA for 10 min, at 4 °C, permeabilize with 0,2 % saponin or digitonin for 15 min, at 4 °C
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- store at 2 - 8 °C
-
-
- UACA (Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA))
-
Alternative Name
- UACA
-
Background
- UACA (Uveal Autoantigen with Coiled-coil domains and Ankyrin repeats) is a 1,416 amino acid nuclear membrane protein. It was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves' disease. UACA was also later identified as Nucling, a mRNA differentially expressed in F9 embryonal carcinoma cells, and that is up-regulated during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway. Positive control: HeLa or 293T cells. Highly expressed in skeletal muscle, heart, kidney and pancreas. Also expressed in epidermal melanocytes, eye muscles and thyroid follicular cells.
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-